Abstract
We examined the association of apolipoprotein E (ApoE) genotype and the risk of early-onset Alzheimer's disease (AD) in 209 white early-onset sporadic cases (43% male) and 303 white controls (48% male) of similar age distribution. The risk of AD was significantly increased, relative to the 3/3 genotype, in people with the 4/4, 3/4, and 2/4 genotypes, controlling for age at time of examination and sex. The 2/3 genotype reduced slightly the risk of AD, although the effect was not statistically significant. We conclude, contrary to some previous reports, that the ApoE ε2 allele does not increase the risk of early-onset sporadic AD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 376-378 |
| Number of pages | 3 |
| Journal | Annals of neurology |
| Volume | 42 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 1 1997 |
| Externally published | Yes |
ASJC Scopus subject areas
- Neurology
- Clinical Neurology
Fingerprint Dive into the research topics of 'Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease'. Together they form a unique fingerprint.
Cite this
Scott, W. K., Saunders, A. M., Gaskell, P. C., Locke, P. A., Growdon, J. H., Farrer, L. A., Auerbach, S. A., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1997). Apolipoprotein E ε2 does not increase risk of early-onset sporadic Alzheimer's disease. Annals of neurology, 42(3), 376-378. https://doi.org/10.1002/ana.410420317